Literature DB >> 4174496

Prolongation of skin homografts by rabbit anti-mouse lymphocyte serum in mice rendered tolerant to rabbit gamma-globulin.

R J Howard, S F Dougherty, S E Mergenhagen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4174496

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response.

Authors:  H F Jeejeebhoy; O Singla
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

2.  The immunogenic components of equine anti-human lymphocyte lobulin in renal allograft recipients.

Authors:  R E Wolf; A R Remmers; H E Sarles; J C Fish; J D Lindley; T M Vyvial; S E Ritzmann
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

3.  [Effect of rabbit anti-mouse lymphocyte gamma globulin on chronic secondary disease in bone marrow donors with tolerance to rabbit normal gamma globulin].

Authors:  S Thierfelder; D Götze; M Eulitz
Journal:  Klin Wochenschr       Date:  1970-12-15

4.  [Immunological tolerance].

Authors:  U Hopf
Journal:  Klin Wochenschr       Date:  1971-02-15

Review 5.  Anti-lymphocytic antibody and autoimmune disease: a review.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

6.  Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin.

Authors:  M E Weksler; G Bull; G H Schwartz; K H Stenzel; A L Rubin
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

7.  Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man.

Authors:  J S Najarian; R L Simmons; H Gewurz; A Moberg; F Merkel; G E Moore
Journal:  Ann Surg       Date:  1969-10       Impact factor: 12.969

8.  Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.

Authors:  V E Jones; E M Lance; J Abbosh; H E Graves
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.